Search

everythinglearnresearchcommunity

for

Search:↓

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

Endogenous neurosteroids may set a baseline mood.

Finasteride can cause lasting skin lightening in women.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Estrogen deficiency can reduce the enzyme activity needed to activate vitamin D.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Resistance exercise can reduce muscle protein issues caused by finasteride.

Spironolactone may reduce excessive hair growth in women but its effectiveness for acne is not supported.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Finasteride 5 mg and topical minoxidil 5% effectively increase hair density in women, with finasteride 5 mg having the highest satisfaction.

A male with aromatase deficiency improved bone health with estradiol treatment.

Long-term finasteride use doesn't change bone density or metabolism.

Alfuzosin reduces short-term surgery need after catheter removal, but long-term benefits are unclear; combination therapy may help prevent urinary issues.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Testosterone therapy may help men with osteoporosis.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

5α-Reductase inhibitors don't cause depression.